Details for Patent: 8,318,201

✉ Email this page to a colleague

Which drugs does patent 8,318,201 protect, and when does it expire?

Patent 8,318,201 protects NOURIANZ and is included in one NDA.

This patent has thirteen patent family members in ten countries.

Summary for Patent: 8,318,201

Title:	Method of stabilizing diarylvinylene compound
Abstract:	##STR00001## (wherein Y.sup.1 and Y.sup.2 may be the same or different and each represents a hydrogen atom, halogen or lower alkyl; and Z and A may be the same or different and each represents substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl) The present invention provides, for example, a method for stabilization of a diarylvinylene compound such as a compound represented by the above formula (I) or the like, or a pharmaceutically acceptable salt thereof in a solid formulation containing the diarylvinylene compound or the pharmaceutically acceptable salt thereof, which comprises allowing an inorganic substance and/or a colorant to exist in the solid formulation, and the like.
Inventor(s):	Uchida; Akihiro (Sunto-gun, JP), Ishikawa; Yasuhiro (Sunto-gun, JP), Ueno; Yasuhiko (Mishima, JP), Kaji; Kiichiro (Machida, JP), Aimoto; Masaharu (Sunto-gun, JP), Kaneko; Naoki (Sunto-gun, JP)
Assignee:	Kyowa Hakko Kirin Co., Ltd. (Tokyo, JP)
Application Number:	10/528,451
Patent Claim Types: see list of patent claims	Use; Composition; Formulation;

Drugs Protected by US Patent 8,318,201

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Kyowa Kirin	NOURIANZ	istradefylline	TABLET;ORAL	022075-001	Aug 27, 2019		RX	Yes	No	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
Kyowa Kirin	NOURIANZ	istradefylline	TABLET;ORAL	022075-002	Aug 27, 2019		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,318,201

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2003-336944	Sep 29, 2003

PCT Information
PCT Filed	September 29, 2004	PCT Application Number:	PCT/JP2004/014687
PCT Publication Date:	April 07, 2005	PCT Publication Number:	WO2005/030219

International Family Members for US Patent 8,318,201

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	046169	⤷ Sign Up
Australia	2004275646	⤷ Sign Up
Canada	2540109	⤷ Sign Up
China	1845742	⤷ Sign Up
European Patent Office	1676578	⤷ Sign Up
Spain	2534220	⤷ Sign Up
Japan	4413866	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.